JP2020531550A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531550A5 JP2020531550A5 JP2020511971A JP2020511971A JP2020531550A5 JP 2020531550 A5 JP2020531550 A5 JP 2020531550A5 JP 2020511971 A JP2020511971 A JP 2020511971A JP 2020511971 A JP2020511971 A JP 2020511971A JP 2020531550 A5 JP2020531550 A5 JP 2020531550A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- formulation according
- migalastat
- mwfs
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022203783A JP2023051998A (ja) | 2017-08-28 | 2022-12-20 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
| JP2025088523A JP2025138638A (ja) | 2017-08-28 | 2025-05-28 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762550984P | 2017-08-28 | 2017-08-28 | |
| US62/550,984 | 2017-08-28 | ||
| PCT/US2018/048257 WO2019046244A1 (en) | 2017-08-28 | 2018-08-28 | METHODS FOR ENHANCING AND / OR STABILIZING CARDIAC FUNCTION IN PATIENTS WITH FABRY DISEASE |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022203783A Division JP2023051998A (ja) | 2017-08-28 | 2022-12-20 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
| JP2025088523A Division JP2025138638A (ja) | 2017-08-28 | 2025-05-28 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531550A JP2020531550A (ja) | 2020-11-05 |
| JP2020531550A5 true JP2020531550A5 (https=) | 2025-06-10 |
| JP7755929B2 JP7755929B2 (ja) | 2025-10-17 |
Family
ID=63528948
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511971A Active JP7755929B2 (ja) | 2017-08-28 | 2018-08-28 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
| JP2022203783A Pending JP2023051998A (ja) | 2017-08-28 | 2022-12-20 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
| JP2025088523A Pending JP2025138638A (ja) | 2017-08-28 | 2025-05-28 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022203783A Pending JP2023051998A (ja) | 2017-08-28 | 2022-12-20 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
| JP2025088523A Pending JP2025138638A (ja) | 2017-08-28 | 2025-05-28 | ファブリー病患者における心臓機能の強化及び／または安定化方法 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20200222377A1 (https=) |
| EP (3) | EP3675853B1 (https=) |
| JP (3) | JP7755929B2 (https=) |
| KR (2) | KR20250049561A (https=) |
| CN (1) | CN111770753A (https=) |
| AR (1) | AR112482A1 (https=) |
| AU (2) | AU2018326364B2 (https=) |
| CA (1) | CA3074450C (https=) |
| CL (1) | CL2020000491A1 (https=) |
| DK (2) | DK3675853T3 (https=) |
| EA (1) | EA202090564A1 (https=) |
| ES (2) | ES2931054T3 (https=) |
| FI (1) | FI4176877T3 (https=) |
| HR (2) | HRP20250064T1 (https=) |
| HU (2) | HUE060287T2 (https=) |
| IL (3) | IL272893B2 (https=) |
| LT (2) | LT3675853T (https=) |
| MX (2) | MX2020002229A (https=) |
| PL (2) | PL4176877T3 (https=) |
| PT (2) | PT3675853T (https=) |
| RS (2) | RS66515B1 (https=) |
| SG (1) | SG11202001707PA (https=) |
| SI (1) | SI4176877T1 (https=) |
| SM (2) | SMT202500073T1 (https=) |
| TW (1) | TWI845479B (https=) |
| WO (1) | WO2019046244A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2533050T6 (pl) | 2006-05-16 | 2016-05-31 | Amicus Therapeutics Inc | Możliwości leczenia choroby Fabry'ego |
| EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
| CA3224546C (en) | 2017-05-30 | 2026-02-24 | Amicus Therapeutics, Inc. | Use of migalastat in the treatment of fabry patients |
| US20200222377A1 (en) | 2017-08-28 | 2020-07-16 | Amicus Therapeutics, Inc. | Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease |
| KR20200128676A (ko) | 2018-02-06 | 2020-11-16 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 임신 환자의 파브리병 치료를 위한 미갈라스타트의 용도 |
| US12594268B2 (en) | 2018-08-20 | 2026-04-07 | Amicus Therapeutics, Inc. | Methods of treating Fabry disease in patients having a mutation in the GLA gene |
| KR20220044560A (ko) * | 2019-08-07 | 2022-04-08 | 아미쿠스 세라퓨틱스, 인코포레이티드 | Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법 |
| US11623916B2 (en) | 2020-12-16 | 2023-04-11 | Amicus Therapeutics, Inc. | Highly purified batches of pharmaceutical grade migalastat and methods of producing the same |
| TR2024011149A1 (tr) | 2024-08-23 | 2026-03-23 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Mi̇galastat i̇çeren kapsül formülasyonlari |
| CN119120696A (zh) * | 2024-11-12 | 2024-12-13 | 北京贝瑞和康生物技术有限公司 | 检测法布雷病gla基因突变的引物组、试剂盒及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| MX2009010557A (es) | 2007-03-30 | 2009-11-19 | Amicus Therapeutics Inc | Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas. |
| US9999618B2 (en) * | 2007-04-26 | 2018-06-19 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
| US20200222377A1 (en) | 2017-08-28 | 2020-07-16 | Amicus Therapeutics, Inc. | Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease |
| EP3676914B1 (en) | 2017-08-28 | 2023-08-16 | John Mezzalingua Associates LLC | Weather protecting (wp) housing for coaxial cable connectors |
-
2018
- 2018-08-28 US US16/642,620 patent/US20200222377A1/en active Pending
- 2018-08-28 CN CN201880056413.8A patent/CN111770753A/zh active Pending
- 2018-08-28 ES ES18766482T patent/ES2931054T3/es active Active
- 2018-08-28 PT PT187664826T patent/PT3675853T/pt unknown
- 2018-08-28 TW TW107129901A patent/TWI845479B/zh active
- 2018-08-28 LT LTEPPCT/US2018/048257T patent/LT3675853T/lt unknown
- 2018-08-28 HU HUE18766482A patent/HUE060287T2/hu unknown
- 2018-08-28 CA CA3074450A patent/CA3074450C/en active Active
- 2018-08-28 DK DK18766482.6T patent/DK3675853T3/da active
- 2018-08-28 ES ES22194251T patent/ES3013820T3/es active Active
- 2018-08-28 MX MX2020002229A patent/MX2020002229A/es unknown
- 2018-08-28 IL IL272893A patent/IL272893B2/en unknown
- 2018-08-28 PL PL22194251.9T patent/PL4176877T3/pl unknown
- 2018-08-28 AR ARP180102438 patent/AR112482A1/es unknown
- 2018-08-28 JP JP2020511971A patent/JP7755929B2/ja active Active
- 2018-08-28 DK DK22194251.9T patent/DK4176877T3/da active
- 2018-08-28 RS RS20250161A patent/RS66515B1/sr unknown
- 2018-08-28 HR HRP20250064TT patent/HRP20250064T1/hr unknown
- 2018-08-28 EP EP18766482.6A patent/EP3675853B1/en active Active
- 2018-08-28 EP EP24217100.7A patent/EP4588476A1/en active Pending
- 2018-08-28 HU HUE22194251A patent/HUE070433T2/hu unknown
- 2018-08-28 HR HRP20221366TT patent/HRP20221366T1/hr unknown
- 2018-08-28 PT PT221942519T patent/PT4176877T/pt unknown
- 2018-08-28 LT LTEP22194251.9T patent/LT4176877T/lt unknown
- 2018-08-28 PL PL18766482.6T patent/PL3675853T3/pl unknown
- 2018-08-28 SI SI201831201T patent/SI4176877T1/sl unknown
- 2018-08-28 KR KR1020257010249A patent/KR20250049561A/ko active Pending
- 2018-08-28 FI FIEP22194251.9T patent/FI4176877T3/fi active
- 2018-08-28 WO PCT/US2018/048257 patent/WO2019046244A1/en not_active Ceased
- 2018-08-28 SM SM20250073T patent/SMT202500073T1/it unknown
- 2018-08-28 AU AU2018326364A patent/AU2018326364B2/en active Active
- 2018-08-28 SM SM20220459T patent/SMT202200459T1/it unknown
- 2018-08-28 RS RS20221061A patent/RS63742B1/sr unknown
- 2018-08-28 EP EP22194251.9A patent/EP4176877B1/en active Active
- 2018-08-28 EA EA202090564A patent/EA202090564A1/ru unknown
- 2018-08-28 IL IL310648A patent/IL310648A/en unknown
- 2018-08-28 SG SG11202001707PA patent/SG11202001707PA/en unknown
- 2018-08-28 KR KR1020207008736A patent/KR102790184B1/ko active Active
-
2020
- 2020-02-27 MX MX2023005628A patent/MX2023005628A/es unknown
- 2020-02-28 CL CL2020000491A patent/CL2020000491A1/es unknown
-
2022
- 2022-12-20 JP JP2022203783A patent/JP2023051998A/ja active Pending
-
2024
- 2024-11-27 AU AU2024266945A patent/AU2024266945A1/en active Pending
-
2025
- 2025-05-28 JP JP2025088523A patent/JP2025138638A/ja active Pending
- 2025-10-23 IL IL324182A patent/IL324182A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020531550A5 (https=) | ||
| ES2150889T3 (es) | Combinacion de glibenclamida-metformina para el tratamiento de la diabetes mellitus tipo ii. | |
| IL272893B1 (en) | Methods of enhancing and/or stabilizing cardiac function in patients with fabry disease | |
| KR20200016889A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| AU2007201808B2 (en) | A method for alleviating signs and symptoms of spasticity | |
| JP2016520653A5 (https=) | ||
| JP2017510607A5 (https=) | ||
| AU2003301188B2 (en) | Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines | |
| JP2021512896A5 (https=) | ||
| Makowski et al. | Naltrexone/bupropion: an investigational combination for weight loss and maintenance | |
| US20180221315A1 (en) | Combination therapy using acamprosate and d-cycloserine | |
| US20080311196A1 (en) | All Day Rhinitic Condition Treatment Regimen | |
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| US20160128954A1 (en) | Methods of Treating Huntington's Disease Using Cysteamine Compositions | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| CN119730840A (zh) | 用于治疗重度抑郁症的1-(萘-2-基)-3-氮杂双环[3.1.0]己烷 | |
| JP2024520510A (ja) | 薬物抵抗性てんかんを処置する方法 | |
| RU2837048C1 (ru) | Долгосрочный реабсорбируемый подкожный имплантат с устойчивым высвобождением предварительно концентрированного фармакологически активного вещества в полимере для лечения болезни паркинсона | |
| TWI752282B (zh) | 苯甲酸或其鹽及衍生物用於預防或治療憂鬱症之用途 | |
| JP2026506886A (ja) | ドキシサイクリン単独またはレボドパとの組み合わせによる神経変性障害の治療 | |
| Mohamed | Parkinson’s Disease medications: In correlation to the Unified Parkinson’s disease rating scale | |
| Nakaki | Drugs That Affect Autonomic Functions or the Extrapyramidal System | |
| Sharma et al. | Comparison of alprazolam and low-dose of risperidone as an adjunctive therapy to enalapril in the treatment of mild-to-moderate essential hypertension | |
| NZ790449B2 (en) | Treatment of fabry disease in ert-naïve and ert-experienced patients | |
| NZ790449A (en) | Treatment of fabry disease in ert-naïve and ert-experienced patients |